Immuno-engineering and Cellular Therapies

W4 - Tolerogenic Dendritic Cells Engineered with a Lentiviral Vector Encoding for IL-10 and Antigen Control T Cell Responses to Pathogenic Antigens

Th1 - Clinical Grade CD8+T Regulatory Cells Moving Forward in Human Transplantation

W11 - Combination of ImmTOR Tolerogenic Nanoparticles and IL-2 Mutein Induces Massive Expansion of Antigen-specific Regulatory T Cells

W19 - MHC-deficient CD8+ Tregs as Universally Compatible Cell Therapy

W62 - Osteosarcoma Tumorigenesis is Affected by Macrophage Behavior in 3D Engineered Bone Marrow Model

W68 - Human CD4+CD25+ Regulatory T Cells Deficient of CD226 Demonstrate Increased Purity and Lineage Stability Following Ex Vivo Expansion for Adoptive Treg Therapies

Th26 - CRISPR-Mediated Deletion of PD1 to Enhance the Efficacy of Human CAR Tregs

Th33 - Developing Islet Antigen-Specific Regulatory T Cell For Therapy in Type 1 Diabetes

Th39 - The Role of Chimeric Antigen Receptor (CAR) Versus Endogenous Co-stimulation in the Function of Alloantigen-specific Tregs

Th50 - Elucidating Inflammation-induced Cell Fate Decisions in Primary Human Tregs

Th61 - The Tolerogenic Effects of IL-2 on T Regulatory Cells (Tregs) are TGF-β Dependent

Tu71 - Synthekines: A Novel Platform for Combinatorial Engineering of Cytokine Receptor Agonists

Tu76 - A Robust, Xeno- and Feeder-Free Culture System for Expansion of Human Peripheral Blood NK Cells

Tu80 - Discovery of T Cell Receptors for Adoptive T Cell Therapy Against Solid Tumors

W118 - Ex vivo Production Of Immunotherapeutic NK Cells From Cord Blood Or Mobilized Peripheral Blood CD34+ Cells Using Notch Ligand Delta-Like 4 Culture System

W119 - Neurofilament Light Chain Levels as a Potential Biomarker of Immune effector Cell-Associated Neurotoxicity Syndrome (ICANS) in Patients Treated with CAR T Cell Therapy

W121 - Modulating Innate Immune Signaling with Nanomaterials to Drive Antigen-Specific Tolerance

W157 - Segregating the Regional Effects of Aging and Blood Immune Factors on Age Related Brain Athrophy

Th127 - Engineered Single Amino Acid Substitutions Protect Therapeutic Cells From CD123 Targeted Immunotherapy in vitro

Th139 - Engineering Optimized Autoreactive T Cells for the Study of Type 1 Diabetes Pathogenesis

Th140 - CAR-T Cells Mediated B Cell Depletion in EAE-induced Disease

Th146 - Chimeric Antigen Receptor Regulatory T Cells (CAR-Tregs) Provide Significantly Greater Modulation of Alloimmune Responses than Alternative Alloantigen-Specific Treg Strategies

Tu105 - A Screening Platform for Drug Effects on Vaccine Responses Using Human Tonsil Immune Organoids

Tu108 - Immunogenicity Induced by Full Academic CD19 Chimeric Antigen Receptor (ARI0001) in Patients Recruited into the CART-BE-01 Clinical Trial

Tu117 - Deep Molecular Comparison Between Lymphoid Progenitor Cells Differentiated from CB or mPB CD34+ Hematopoietic Stem Cells Cultivated on Notch Ligand DLL4 Through a Clinically Compatible Culture Procedure

Tu229 - Two-dimensional Materials for Biomedical Applications: MXenes Immune Profiling